Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1986 1
1988 1
1989 1
1992 2
1994 1
1995 2
1996 2
1997 1
1998 1
1999 1
2000 1
2002 4
2003 1
2004 4
2005 4
2006 5
2007 4
2008 4
2009 3
2010 2
2011 7
2012 6
2013 7
2014 13
2015 8
2016 5
2017 4
2018 3
2019 2
2020 1
2021 5
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Mucosal telangiectasiae"
Page 1
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy.
Kim R, Kwon M, An M, Kim ST, Smith SA, Loembé AB, Mortimer PGS, Armenia J, Lukashchuk N, Shah N, Dean E, Park WY, Lee J. Kim R, et al. Ann Oncol. 2022 Feb;33(2):193-203. doi: 10.1016/j.annonc.2021.10.009. Epub 2021 Oct 25. Ann Oncol. 2022. PMID: 34710570 Free article. Clinical Trial.
RESULTS: Among the 30 patients, we observed an overall response rate of 31.0% and a disease control rate of 63.3%. Responses were evident across patients with acral, mucosal, and cutaneous melanoma. The median duration of response was 8.8 months (range, 3.8-11.7 mon …
RESULTS: Among the 30 patients, we observed an overall response rate of 31.0% and a disease control rate of 63.3%. Responses were evi …
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge.
Veronesi G, Virdi A, Leuzzi M, Gurioli C, Chessa MA, Guglielmo A, Neri I. Veronesi G, et al. Pediatr Dermatol. 2021 Sep;38(5):1012-1019. doi: 10.1111/pde.14771. Epub 2021 Sep 24. Pediatr Dermatol. 2021. PMID: 34561885 Review.
Vulvar vitiligo (VV) and vulvar lichen sclerosus (VLS), both feature skin and mucosal hypo-/depigmentation. The aim of this study was to describe the clinical and dermoscopic features of VV and VLS in the pediatric population, providing diagnostic clues, and to define thei …
Vulvar vitiligo (VV) and vulvar lichen sclerosus (VLS), both feature skin and mucosal hypo-/depigmentation. The aim of this study was …
Skin and mucosal telangiectatic lesions in hereditary hemorrhagic telangiectasia patients.
Hyldahl SJ, El-Jaji MQ, Schuster A, Kjeldsen AD. Hyldahl SJ, et al. Int J Dermatol. 2022 Dec;61(12):1497-1505. doi: 10.1111/ijd.16320. Epub 2022 Jul 6. Int J Dermatol. 2022. PMID: 35792874 Free PMC article. Review.
BACKGROUND: The diagnostic criteria for hereditary hemorrhagic telangiectasia (HHT) include the presence of telangiectatic lesions in common sites (nose, fingers, oral cavity, and lips). ...However, elongated flat lesions and larger round, elevated lesions were also obs …
BACKGROUND: The diagnostic criteria for hereditary hemorrhagic telangiectasia (HHT) include the presence of telangiectatic lesions in …
Identifying racial disparities in hereditary hemorrhagic telangiectasia.
Yusuf H, Rasheed A, Kim H, Conrad MB, Hetts SW. Yusuf H, et al. J Neurointerv Surg. 2023 Oct;15(10):1050-1054. doi: 10.1136/jnis-2022-019162. Epub 2022 Sep 22. J Neurointerv Surg. 2023. PMID: 36137744 Review.
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder characterized by recurrent epistaxis (nose bleeds), mucosal telangiectasias (spider veins), and arteriovenous malformations. ...The primary outcomes of this study we …
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder characterized by recurrent epistaxis (n …
Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.
Vigarios E, Epstein JB, Sibaud V. Vigarios E, et al. Support Care Cancer. 2017 May;25(5):1713-1739. doi: 10.1007/s00520-017-3629-4. Epub 2017 Feb 22. Support Care Cancer. 2017. PMID: 28224235 Review.
Development of biological targeted therapies and immune checkpoint inhibitors has redefined the treatment for many cancers; however, the increasing use of new protocols has led to physicians observing a new spectrum of toxicities. To date, oral adverse events induced by th …
Development of biological targeted therapies and immune checkpoint inhibitors has redefined the treatment for many cancers; however, the inc …
Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B, Abdel-Aty Y, Marks L, Lal D, Marino M. Thiele B, et al. Ann Otol Rhinol Laryngol. 2023 Jan;132(1):82-90. doi: 10.1177/00034894221078075. Epub 2022 Feb 12. Ann Otol Rhinol Laryngol. 2023. PMID: 35152768 Review.
OBJECTIVES: Hereditary hemorrhagic telangiectasia (HHT) is a common inherited condition characterized by mucosal telangiectasias, recurrent epistaxis, and arteriovenous malformations. ...Reported variables included number of injections, months of follow up, c …
OBJECTIVES: Hereditary hemorrhagic telangiectasia (HHT) is a common inherited condition characterized by mucosal telangiect …
Clinical and dermoscopic spectrum of discoid lupus erythematosus: novel observations from lips and oral mucosa.
Salah E. Salah E. Int J Dermatol. 2018 Jul;57(7):830-836. doi: 10.1111/ijd.14015. Epub 2018 Apr 27. Int J Dermatol. 2018. PMID: 29700807
A significant correlation was found between lesion's age and the following dermoscopic criteria: (early lesions: follicular keratotic plugs and perifollicular white halos; while late lesions: telangiectasia and white structureless areas). Furthermore, telangiectasia …
A significant correlation was found between lesion's age and the following dermoscopic criteria: (early lesions: follicular keratotic plugs …
Ado-trastuzumab emtansine associated spider telangiectasia.
Gursoy P, Acar A, Acikalin T. Gursoy P, et al. J Oncol Pharm Pract. 2022 Jun;28(4):986-988. doi: 10.1177/10781552211073878. Epub 2022 Jan 18. J Oncol Pharm Pract. 2022. PMID: 35040682
CASE REPORT: In our case, we reported our patient who developed mucosal and cutaneous telangiectasia after T-DM1 treatment and who had a complete response in metastases after skin lesions. MANAGEMENT AND OUTCOME: While no side effects were observed during the …
CASE REPORT: In our case, we reported our patient who developed mucosal and cutaneous telangiectasia after T-DM1 treatment and …
Colonic mucosal changes in patients with liver cirrhosis.
Tam TN, NG WW, Lee SD. Tam TN, et al. Gastrointest Endosc. 1995 Nov;42(5):408-12. doi: 10.1016/s0016-5107(95)70040-4. Gastrointest Endosc. 1995. PMID: 8566628
Pathologic findings in patients with telangiectasiae or angiodysplastic-like lesions showed dilation of vessels (7 of 9 patients) and edema of mucosa (6 of 9 patients). There was no correlation between the severity of cirrhosis, grade of esophageal varices, and the presenc …
Pathologic findings in patients with telangiectasiae or angiodysplastic-like lesions showed dilation of vessels (7 of 9 patients) and …
Arteriovenous malformations and other vascular malformation syndromes.
Whitehead KJ, Smith MC, Li DY. Whitehead KJ, et al. Cold Spring Harb Perspect Med. 2013 Feb 1;3(2):a006635. doi: 10.1101/cshperspect.a006635. Cold Spring Harb Perspect Med. 2013. PMID: 23125071 Free PMC article. Review.
In these and other hereditary vascular malformation syndromes, genetic studies have identified proteins and pathways involved in vascular morphogenesis and development. A common theme observed is that vascular malformations result from disruption in pathways involved in va …
In these and other hereditary vascular malformation syndromes, genetic studies have identified proteins and pathways involved in vascular mo …
103 results